Telmisartan and Cardioprotection

Vascular Health and Risk Management
doi 10.2147/vhrm.s9447
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Informa UK Limited

Related search

Potassium Channels and Cardioprotection

2012English

Is Cardioprotection Dead?

Circulation
Cardiovascular MedicinePhysiologyCardiology
2017English

Comparison of the Efficacy and Safety of Fixed-Dose S-Amlodipine/Telmisartan and Telmisartan in Hypertensive Patients Inadequately Controlled With Telmisartan: A Randomized, Double-Blind, Multicenter Study

Clinical Therapeutics
Pharmacology
2016English

Telmisartan: A Multifaceted Antihypertension Drug

Current Medical Research and Opinion
Medicine
2016English

Redox Signalling and Cardioprotection: Translatability and Mechanism

British Journal of Pharmacology
Pharmacology
2015English

Cardioprotection: Nitric Oxide, Protein Kinases, and Mitochondria

Circulation
Cardiovascular MedicinePhysiologyCardiology
2008English

Telmisartan: The ACE of ARBs?

Hypertension
Internal Medicine
2006English

Harnessing Hormonal Signaling for Cardioprotection

Science of Aging Knowledge Environment
2005English

Targeting Pathological Remodeling : Concepts of Cardioprotection and Reparation

Circulation
Cardiovascular MedicinePhysiologyCardiology
2000English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy